MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

  1. Melguizo, C.
  2. Prados, J.
  3. González, B.
  4. Ortiz, R.
  5. Concha, A.
  6. Alvarez, P.J.
  7. Madeddu, R.
  8. Perazzoli, G.
  9. Oliver, J.A.
  10. López, R.
  11. Rodríguez-Serrano, F.
  12. Aránega, A.
Revista:
Journal of Translational Medicine

ISSN: 1479-5876

Any de publicació: 2012

Volum: 10

Número: 1

Tipus: Article

DOI: 10.1186/1479-5876-10-250 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus